Skip to main content
Erschienen in: Cancer Causes & Control 11/2018

07.09.2018 | Original paper

Differences in cancer survival by sex: a population-based study using cancer registry data

verfasst von: Nina Afshar, Dallas R. English, Vicky Thursfield, Paul L. Mitchell, Luc Te Marvelde, Helen Farrugia, Graham G. Giles, Roger L. Milne

Erschienen in: Cancer Causes & Control | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Few large-scale studies have investigated sex differences in cancer survival and little is known about their temporal and age-related patterns.

Methods

We used cancer registry data for first primary cancers diagnosed between 1982 and 2015 in Victoria, Australia. Cases were followed until the end of 2015 through linkage to death registries. Differences in survival were assessed for 25 cancers using the Pohar-Perme estimator of net survival and the excess mortality rate ratio (EMRR) adjusting for age and year of diagnosis.

Results

Five-year net survival for all cancers combined was lower for men (47.1%; 95% CI 46.9–47.4) than women (52.0%; 95% CI 51.7–52.3); EMRR 1.13 (95% CI 1.12–1.14; p < 0.001). A survival disadvantage for men was observed for 11 cancers: head and neck, esophagus, colorectum, pancreas, lung, bone, melanoma, mesothelioma, kidney, thyroid, and non-Hodgkin lymphoma. In contrast, women had lower survival from cancers of the bladder, renal pelvis, and ureter. For the majority of cancers with survival differences, the EMRR decreased with increasing age at diagnosis; for colorectal, esophageal, and kidney cancer, the EMRR increased with time since diagnosis.

Conclusion

Identifying the underlying reasons behind sex differences in cancer survival is necessary to address inequalities, which may improve outcomes for men and women.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pardue ML (2001) Exploring the biological contributions to human health: does sex matter? J Women’s Health Gend Based Med 10(5):433–439CrossRef Pardue ML (2001) Exploring the biological contributions to human health: does sex matter? J Women’s Health Gend Based Med 10(5):433–439CrossRef
5.
Zurück zum Zitat Sagerup CM, Småstuen M, Johannesen TB, Helland Å, Brustugun OT (2011) Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases. Thorax 66(4):301–307CrossRef Sagerup CM, Småstuen M, Johannesen TB, Helland Å, Brustugun OT (2011) Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases. Thorax 66(4):301–307CrossRef
6.
Zurück zum Zitat Ulas A, Tokluoglu S, Kos M, Silay K, Akinci S, Oksuzoglu B, Alkis N (2015) Lung cancer in women, a different disease: survival differences by sex in Turkey. Asian Pac J Cancer Prev 16(2):815–822CrossRef Ulas A, Tokluoglu S, Kos M, Silay K, Akinci S, Oksuzoglu B, Alkis N (2015) Lung cancer in women, a different disease: survival differences by sex in Turkey. Asian Pac J Cancer Prev 16(2):815–822CrossRef
8.
Zurück zum Zitat Wisnivesky JP, Halm EA (2007) Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol 25(13):1705–1712CrossRef Wisnivesky JP, Halm EA (2007) Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol 25(13):1705–1712CrossRef
12.
Zurück zum Zitat Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, Coebergh JWW, Eggermont AM, de Vries E (2012) Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol 30(18):2240–2247CrossRef Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, Coebergh JWW, Eggermont AM, de Vries E (2012) Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol 30(18):2240–2247CrossRef
13.
Zurück zum Zitat de Vries E, Nijsten TEC, Visser O, Bastiaannet E, van Hattem S, Janssen-Heijnen ML, Coebergh JWW (2008) Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. AnnOncol 19(3):583–589 de Vries E, Nijsten TEC, Visser O, Bastiaannet E, van Hattem S, Janssen-Heijnen ML, Coebergh JWW (2008) Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. AnnOncol 19(3):583–589
14.
Zurück zum Zitat Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ (2006) Gender-related differences in outcome for melanoma patients. Ann Surg 243(5):693CrossRef Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ (2006) Gender-related differences in outcome for melanoma patients. Ann Surg 243(5):693CrossRef
16.
Zurück zum Zitat Tracey E, Watt H, Currow D, Young J, Armstrong B (2014) Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study. BJU Int 113(3):437–448CrossRef Tracey E, Watt H, Currow D, Young J, Armstrong B (2014) Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study. BJU Int 113(3):437–448CrossRef
17.
Zurück zum Zitat Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55(6):876–880CrossRef Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55(6):876–880CrossRef
18.
Zurück zum Zitat Waldhoer T, Berger I, Haidinger G, Zielonke N, Madersbacher S (2015) Sex Differences of ≥ pT1 Bladder Cancer Survival in Austria: A descriptive, long-term, nation-wide analysis based on 27,773 Patients. Urol Int 94(4):383–389CrossRef Waldhoer T, Berger I, Haidinger G, Zielonke N, Madersbacher S (2015) Sex Differences of ≥ pT1 Bladder Cancer Survival in Austria: A descriptive, long-term, nation-wide analysis based on 27,773 Patients. Urol Int 94(4):383–389CrossRef
20.
Zurück zum Zitat Ellison LF (2016) Differences in cancer survival in Canada by sex. Health Rep 27(4):19PubMed Ellison LF (2016) Differences in cancer survival in Canada by sex. Health Rep 27(4):19PubMed
23.
Zurück zum Zitat Oberaigner W, Siebert U (2011) Do women with cancer have better survival as compared to men after adjusting for staging distribution? Eur J Pub Health 21(3):387–391CrossRef Oberaigner W, Siebert U (2011) Do women with cancer have better survival as compared to men after adjusting for staging distribution? Eur J Pub Health 21(3):387–391CrossRef
24.
Zurück zum Zitat Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF (2011) Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev 20(8):1629–1637CrossRef Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF (2011) Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev 20(8):1629–1637CrossRef
26.
Zurück zum Zitat Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P (1998) The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. Eur J Cancer 34(14 Spec No):2271–2278CrossRef Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P (1998) The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. Eur J Cancer 34(14 Spec No):2271–2278CrossRef
27.
Zurück zum Zitat Ellison L, Gibbons L (2001) Five-year relative survival from prostate, breast, colorectal and lung cancer. Health Rep 13(1):23–34PubMed Ellison L, Gibbons L (2001) Five-year relative survival from prostate, breast, colorectal and lung cancer. Health Rep 13(1):23–34PubMed
28.
Zurück zum Zitat Australian Consortium for Classification Development. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM/ACHI/ACS) Independent Hospital Pricing Authority, Darlinghurst, NSW Australian Consortium for Classification Development. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM/ACHI/ACS) Independent Hospital Pricing Authority, Darlinghurst, NSW
29.
Zurück zum Zitat Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835–3849CrossRef Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835–3849CrossRef
30.
Zurück zum Zitat Australian Blood Cancer Registry (2008) Report of the third annual stakeholder meeting, Stamford Plaza Sydney Airport, October 2007. Sydney: ABCR Australian Blood Cancer Registry (2008) Report of the third annual stakeholder meeting, Stamford Plaza Sydney Airport, October 2007. Sydney: ABCR
31.
Zurück zum Zitat Egevad L, Heanue M, Berney D, Fleming K, Ferlay J (2007) Histological groups. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Byle P (eds) Cancer incidence in five continents. IARC Scientific Publications, Lyon pp 61–66 Egevad L, Heanue M, Berney D, Fleming K, Ferlay J (2007) Histological groups. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Byle P (eds) Cancer incidence in five continents. IARC Scientific Publications, Lyon pp 61–66
33.
Zurück zum Zitat Coviello E, Dickman PW, Seppå K, Pokhrel A (2015) Estimating net survival using a life-table approach. The Stata Journal 15:173–185 Coviello E, Dickman PW, Seppå K, Pokhrel A (2015) Estimating net survival using a life-table approach. The Stata Journal 15:173–185
35.
Zurück zum Zitat Dickman PW, Coviello E (2015) Estimating and modeling relative survival. Stat J 15(1):186–215 Dickman PW, Coviello E (2015) Estimating and modeling relative survival. Stat J 15(1):186–215
36.
Zurück zum Zitat Brenner H, Hakulinen T (2007) Patients with previous cancer should not be excluded in international comparative cancer survival studies. Int J Cancer 121(10):2274–2278CrossRef Brenner H, Hakulinen T (2007) Patients with previous cancer should not be excluded in international comparative cancer survival studies. Int J Cancer 121(10):2274–2278CrossRef
44.
Zurück zum Zitat Marks P, Soave A, Shariat SF, Fajkovic H, Fisch M, Rink M (2016) Female with bladder cancer: what and why is there a difference? Trans Androl Urol 5(5):668–682CrossRef Marks P, Soave A, Shariat SF, Fajkovic H, Fisch M, Rink M (2016) Female with bladder cancer: what and why is there a difference? Trans Androl Urol 5(5):668–682CrossRef
45.
Zurück zum Zitat Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP (2013) Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open 3(6):1CrossRef Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP (2013) Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open 3(6):1CrossRef
48.
Zurück zum Zitat Shahabi S, He S, Kopf M, Mariani M, Petrini J, Scambia G, Ferlini C (2013) Free testosterone drives cancer aggressiveness: evidence from US population studies. PLoS ONE 8(4):e61955CrossRef Shahabi S, He S, Kopf M, Mariani M, Petrini J, Scambia G, Ferlini C (2013) Free testosterone drives cancer aggressiveness: evidence from US population studies. PLoS ONE 8(4):e61955CrossRef
49.
Zurück zum Zitat Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L (2016) Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med 375(7):614–617CrossRef Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L (2016) Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med 375(7):614–617CrossRef
50.
Zurück zum Zitat Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk B, Chirlaque M, Capocaccia R, Larrañaga N, Colonna M, Agius D (2017) Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 77:140–152CrossRef Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk B, Chirlaque M, Capocaccia R, Larrañaga N, Colonna M, Agius D (2017) Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 77:140–152CrossRef
51.
Zurück zum Zitat Pandeya N, Wilson LF, Bain CJ, Martin KL, Webb PM, Whiteman DC (2015) Cancers in Australia in 2010 attributable to tobacco smoke. Aust N Z J Public Health 39(5):464–470CrossRef Pandeya N, Wilson LF, Bain CJ, Martin KL, Webb PM, Whiteman DC (2015) Cancers in Australia in 2010 attributable to tobacco smoke. Aust N Z J Public Health 39(5):464–470CrossRef
Metadaten
Titel
Differences in cancer survival by sex: a population-based study using cancer registry data
verfasst von
Nina Afshar
Dallas R. English
Vicky Thursfield
Paul L. Mitchell
Luc Te Marvelde
Helen Farrugia
Graham G. Giles
Roger L. Milne
Publikationsdatum
07.09.2018
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 11/2018
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1079-z

Weitere Artikel der Ausgabe 11/2018

Cancer Causes & Control 11/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.